INCT 2014 - pharmaceutical nanotechnology: a transdisciplinary approach - Proc. n. 2014 / 50928-2, vitrocell system View Homepage


Ontology type: schema:MonetaryGrant     


Grant Info

YEARS

2017-2024

FUNDING AMOUNT

N/A

ABSTRACT

INCT NANOFARMA represents an important strategy for the already consolidated association of skills of several universities in Brazil in the field of nanotechnology applied to medicine and cosmetics, which works in the development of projects related to obtaining nanocarriers for various molecules with biological activity, for their application in therapies where nanotechnology can add therapeutic values, to promote the development of techniques and processes for the production, characterization and evaluation of these products, as well as the understanding of chemical and biological aspects (mechanistic studies of the interaction of these systems with tissues / cells and toxicology ) involved in obtaining and using these drugs. INCT NANOFARMA focuses on Pharmaceutical Nanotechnology, on transdisciplinary aspects of the material. It will add technical knowledge and expand the possibilities of innovation between Universities and the company. Research and projects related to INCT NANOFARMA platforms will be developed to seek understanding of the different aspects involved in the science of nanotechnology-based drugs. The INCT NANOFARMA researchers through their projects, employees and laboratories will act in a more specific way in a certain platform, but will permeate others, showing the articulation of the group in the main research themes of this proposal. The INCT NANOFARMA has 49 researchers, involving 14 universities (USP SP and RP, UFRGS, UFRJ, UFMG, UFPE, UFOP, UFSC, UNESP, UFSM, UFG, UNB, UNISO, UFPe), a foundation (FUNED) and Extensive coverage in the national territory, with the participation of 08 Brazilian states (SP, RS, RJ, MG, SC, DF, GO, PE). In this formation, INCT NANOFARMA covers 4 regions of Brazil, namely Southeast, Northeast, Midwest and South, which highlights the institutional and national coverage of the group. INCT NANOFARMA also involves 07 foreign researchers of renowned knowledge in the field of Nanomedicine. These researchers already have scientific interactions with INCT NANOFARMA, thus emphasizing the international reach and articulations of groups internationally. It adds up to 08 staff consultants and 05 abroad. All of them have recognized recognition in the area of ​​Nanotechnology in Brazil and abroad. INCT NANOFARMA aims to advance scientific and technological development in Nanotechnology Pharmaceuticals, a knowledge-based area, with the objective of enabling technological platforms in two strategic areas (health and nanotechnology) to obtain innovative medicines for the business sector through an approach transdisciplinary. Thus, INCT NANOFARMA will contribute to the resolution of national problems related to drug development. Strategically, the project will develop technological proposals based on the therapeutic benefits that nanotechnology can offer to drug administration. In this context, INCT NANOFARMA also aims to develop internationalization, transfer of knowledge to the business sector (public and private) and community activities, besides acting as articulator of research networks and nucleation of new groups in nanotechnology area of ​​nanotechnology based drugs . (AU) More... »

URL

http://www.bv.fapesp.br/pt/auxilios/98008/inct-2014-nanotecnologia-farmaceutica-uma-abordagem-transdisciplinar-proc-n-201450928-2-vit/

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2203", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "description": "INCT NANOFARMA represents an important strategy for the already consolidated association of skills of several universities in Brazil in the field of nanotechnology applied to medicine and cosmetics, which works in the development of projects related to obtaining nanocarriers for various molecules with biological activity, for their application in therapies where nanotechnology can add therapeutic values, to promote the development of techniques and processes for the production, characterization and evaluation of these products, as well as the understanding of chemical and biological aspects (mechanistic studies of the interaction of these systems with tissues / cells and toxicology ) involved in obtaining and using these drugs. INCT NANOFARMA focuses on Pharmaceutical Nanotechnology, on transdisciplinary aspects of the material. It will add technical knowledge and expand the possibilities of innovation between Universities and the company. Research and projects related to INCT NANOFARMA platforms will be developed to seek understanding of the different aspects involved in the science of nanotechnology-based drugs. The INCT NANOFARMA researchers through their projects, employees and laboratories will act in a more specific way in a certain platform, but will permeate others, showing the articulation of the group in the main research themes of this proposal. The INCT NANOFARMA has 49 researchers, involving 14 universities (USP SP and RP, UFRGS, UFRJ, UFMG, UFPE, UFOP, UFSC, UNESP, UFSM, UFG, UNB, UNISO, UFPe), a foundation (FUNED) and Extensive coverage in the national territory, with the participation of 08 Brazilian states (SP, RS, RJ, MG, SC, DF, GO, PE). In this formation, INCT NANOFARMA covers 4 regions of Brazil, namely Southeast, Northeast, Midwest and South, which highlights the institutional and national coverage of the group. INCT NANOFARMA also involves 07 foreign researchers of renowned knowledge in the field of Nanomedicine. These researchers already have scientific interactions with INCT NANOFARMA, thus emphasizing the international reach and articulations of groups internationally. It adds up to 08 staff consultants and 05 abroad. All of them have recognized recognition in the area of \u200b\u200bNanotechnology in Brazil and abroad. INCT NANOFARMA aims to advance scientific and technological development in Nanotechnology Pharmaceuticals, a knowledge-based area, with the objective of enabling technological platforms in two strategic areas (health and nanotechnology) to obtain innovative medicines for the business sector through an approach transdisciplinary. Thus, INCT NANOFARMA will contribute to the resolution of national problems related to drug development. Strategically, the project will develop technological proposals based on the therapeutic benefits that nanotechnology can offer to drug administration. In this context, INCT NANOFARMA also aims to develop internationalization, transfer of knowledge to the business sector (public and private) and community activities, besides acting as articulator of research networks and nucleation of new groups in nanotechnology area of \u200b\u200bnanotechnology based drugs . (AU)", 
    "endDate": "2024-09-30T00:00:00Z", 
    "funder": {
      "id": "https://www.grid.ac/institutes/grid.452907.d", 
      "type": "Organization"
    }, 
    "id": "sg:grant.7443422", 
    "identifier": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "7443422"
        ]
      }, 
      {
        "name": "fapesp_id", 
        "type": "PropertyValue", 
        "value": [
          "17/17076-0"
        ]
      }
    ], 
    "inLanguage": [
      "pt"
    ], 
    "keywords": [
      "evaluation", 
      "groups", 
      "INCT", 
      "RS", 
      "toxicology", 
      "transfer", 
      "articulation", 
      "process", 
      "health", 
      "cosmetics", 
      "technological development", 
      "main research themes", 
      "Mg", 
      "development", 
      "Brazil", 
      "therapy", 
      "others", 
      "understanding", 
      "business sector", 
      "international reach", 
      "specific ways", 
      "companies", 
      "context", 
      "several universities", 
      "FUNED", 
      "Au", 
      "association", 
      "internationalization", 
      "UFoP", 
      "SC", 
      "project", 
      "UFSC", 
      "extensive coverage", 
      "laboratory", 
      "UFMG", 
      "\u200b\u200bnanotechnology", 
      "SP", 
      "Drug Administration", 
      "various molecules", 
      "UFG", 
      "certain platforms", 
      "possibility", 
      "region", 
      "2014 - pharmaceutical nanotechnology", 
      "USP SP", 
      "different aspects", 
      "innovative medicines", 
      "therapeutic value", 
      "recognition", 
      "PE", 
      "nanotechnology", 
      "northeast", 
      "application", 
      "UNESP", 
      "community activities", 
      "approach transdisciplinary", 
      "renowned knowledge", 
      "articulator", 
      "southeast", 
      "participation", 
      "RJ", 
      "n. 2014 / 50928", 
      "researchers", 
      "UFSM", 
      "Nanotechnology Pharmaceuticals", 
      "drugs", 
      "foreign researchers", 
      "area", 
      "Midwest", 
      "science", 
      "technique", 
      "biological activity", 
      "knowledge", 
      "system", 
      "UFRGS", 
      "transdisciplinary aspects", 
      "DF", 
      "proposal", 
      "national coverage", 
      "new group", 
      "staff consultants", 
      "besides", 
      "south", 
      "INCT NANOFARMA", 
      "RP", 
      "medicine", 
      "chemical", 
      "resolution", 
      "therapeutic benefit", 
      "Uniso", 
      "strategic areas", 
      "INCT NANOFARMA researchers", 
      "INCT NANOFARMA platforms", 
      "nanomedicine", 
      "nanocarriers", 
      "national territory", 
      "biological aspects", 
      "mechanistic studies", 
      "products", 
      "transdisciplinary approach - Proc", 
      "UFRJ", 
      "production", 
      "technical knowledge", 
      "drug development", 
      "University", 
      "UFPE", 
      "foundation", 
      "research", 
      "interaction", 
      "characterization", 
      "UNB", 
      "innovation", 
      "technological platform", 
      "GO", 
      "scientific interaction", 
      "Brazilian states", 
      "formation", 
      "pharmaceutical nanotechnology", 
      "vitrocell system", 
      "employees", 
      "material", 
      "research network", 
      "tissues/cells", 
      "nanotechnology area", 
      "nucleation", 
      "national problem", 
      "OBJECTIVE", 
      "technological proposals", 
      "skills", 
      "field", 
      "important strategy"
    ], 
    "name": "INCT 2014 - pharmaceutical nanotechnology: a transdisciplinary approach - Proc. n. 2014 / 50928-2, vitrocell system", 
    "recipient": [
      {
        "id": "https://www.grid.ac/institutes/grid.11899.38", 
        "type": "Organization"
      }, 
      {
        "affiliation": {
          "id": "https://www.grid.ac/institutes/grid.11899.38", 
          "name": "Universidade de S\u00e3o Paulo ", 
          "type": "Organization"
        }, 
        "familyName": "Bentley", 
        "givenName": "Maria", 
        "id": "sg:person.01052663343.31", 
        "type": "Person"
      }, 
      {
        "member": "sg:person.01052663343.31", 
        "roleName": "PI", 
        "type": "Role"
      }
    ], 
    "sameAs": [
      "https://app.dimensions.ai/details/grant/grant.7443422"
    ], 
    "sdDataset": "grants", 
    "sdDatePublished": "2019-03-07T11:28", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com.uberresearch.data.processor/core_data/20181219_192338/projects/base/fapesp_projects.xml.gz", 
    "startDate": "2017-10-01T00:00:00Z", 
    "type": "MonetaryGrant", 
    "url": "http://www.bv.fapesp.br/pt/auxilios/98008/inct-2014-nanotecnologia-farmaceutica-uma-abordagem-transdisciplinar-proc-n-201450928-2-vit/"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/grant.7443422'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/grant.7443422'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/grant.7443422'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/grant.7443422'


 

This table displays all metadata directly associated to this object as RDF triples.

171 TRIPLES      18 PREDICATES      152 URIs      144 LITERALS      4 BLANK NODES

Subject Predicate Object
1 sg:grant.7443422 schema:about anzsrc-for:2203
2 schema:description INCT NANOFARMA represents an important strategy for the already consolidated association of skills of several universities in Brazil in the field of nanotechnology applied to medicine and cosmetics, which works in the development of projects related to obtaining nanocarriers for various molecules with biological activity, for their application in therapies where nanotechnology can add therapeutic values, to promote the development of techniques and processes for the production, characterization and evaluation of these products, as well as the understanding of chemical and biological aspects (mechanistic studies of the interaction of these systems with tissues / cells and toxicology ) involved in obtaining and using these drugs. INCT NANOFARMA focuses on Pharmaceutical Nanotechnology, on transdisciplinary aspects of the material. It will add technical knowledge and expand the possibilities of innovation between Universities and the company. Research and projects related to INCT NANOFARMA platforms will be developed to seek understanding of the different aspects involved in the science of nanotechnology-based drugs. The INCT NANOFARMA researchers through their projects, employees and laboratories will act in a more specific way in a certain platform, but will permeate others, showing the articulation of the group in the main research themes of this proposal. The INCT NANOFARMA has 49 researchers, involving 14 universities (USP SP and RP, UFRGS, UFRJ, UFMG, UFPE, UFOP, UFSC, UNESP, UFSM, UFG, UNB, UNISO, UFPe), a foundation (FUNED) and Extensive coverage in the national territory, with the participation of 08 Brazilian states (SP, RS, RJ, MG, SC, DF, GO, PE). In this formation, INCT NANOFARMA covers 4 regions of Brazil, namely Southeast, Northeast, Midwest and South, which highlights the institutional and national coverage of the group. INCT NANOFARMA also involves 07 foreign researchers of renowned knowledge in the field of Nanomedicine. These researchers already have scientific interactions with INCT NANOFARMA, thus emphasizing the international reach and articulations of groups internationally. It adds up to 08 staff consultants and 05 abroad. All of them have recognized recognition in the area of ​​Nanotechnology in Brazil and abroad. INCT NANOFARMA aims to advance scientific and technological development in Nanotechnology Pharmaceuticals, a knowledge-based area, with the objective of enabling technological platforms in two strategic areas (health and nanotechnology) to obtain innovative medicines for the business sector through an approach transdisciplinary. Thus, INCT NANOFARMA will contribute to the resolution of national problems related to drug development. Strategically, the project will develop technological proposals based on the therapeutic benefits that nanotechnology can offer to drug administration. In this context, INCT NANOFARMA also aims to develop internationalization, transfer of knowledge to the business sector (public and private) and community activities, besides acting as articulator of research networks and nucleation of new groups in nanotechnology area of ​​nanotechnology based drugs . (AU)
3 schema:endDate 2024-09-30T00:00:00Z
4 schema:funder https://www.grid.ac/institutes/grid.452907.d
5 schema:identifier N61551ed5e5b740a3987a3eb39738d81e
6 Nd332aad5d1a2434cb9311ed9e32df5ab
7 schema:inLanguage pt
8 schema:keywords 2014 - pharmaceutical nanotechnology
9 Au
10 Brazil
11 Brazilian states
12 DF
13 Drug Administration
14 FUNED
15 GO
16 INCT
17 INCT NANOFARMA
18 INCT NANOFARMA platforms
19 INCT NANOFARMA researchers
20 Mg
21 Midwest
22 Nanotechnology Pharmaceuticals
23 OBJECTIVE
24 PE
25 RJ
26 RP
27 RS
28 SC
29 SP
30 UFG
31 UFMG
32 UFPE
33 UFRGS
34 UFRJ
35 UFSC
36 UFSM
37 UFoP
38 UNB
39 UNESP
40 USP SP
41 Uniso
42 University
43 application
44 approach transdisciplinary
45 area
46 articulation
47 articulator
48 association
49 besides
50 biological activity
51 biological aspects
52 business sector
53 certain platforms
54 characterization
55 chemical
56 community activities
57 companies
58 context
59 cosmetics
60 development
61 different aspects
62 drug development
63 drugs
64 employees
65 evaluation
66 extensive coverage
67 field
68 foreign researchers
69 formation
70 foundation
71 groups
72 health
73 important strategy
74 innovation
75 innovative medicines
76 interaction
77 international reach
78 internationalization
79 knowledge
80 laboratory
81 main research themes
82 material
83 mechanistic studies
84 medicine
85 n. 2014 / 50928
86 nanocarriers
87 nanomedicine
88 nanotechnology
89 nanotechnology area
90 national coverage
91 national problem
92 national territory
93 new group
94 northeast
95 nucleation
96 others
97 participation
98 pharmaceutical nanotechnology
99 possibility
100 process
101 production
102 products
103 project
104 proposal
105 recognition
106 region
107 renowned knowledge
108 research
109 research network
110 researchers
111 resolution
112 science
113 scientific interaction
114 several universities
115 skills
116 south
117 southeast
118 specific ways
119 staff consultants
120 strategic areas
121 system
122 technical knowledge
123 technique
124 technological development
125 technological platform
126 technological proposals
127 therapeutic benefit
128 therapeutic value
129 therapy
130 tissues/cells
131 toxicology
132 transdisciplinary approach - Proc
133 transdisciplinary aspects
134 transfer
135 understanding
136 various molecules
137 vitrocell system
138 ​​nanotechnology
139 schema:name INCT 2014 - pharmaceutical nanotechnology: a transdisciplinary approach - Proc. n. 2014 / 50928-2, vitrocell system
140 schema:recipient N3bb025afe6134940bd303b9887afdb88
141 sg:person.01052663343.31
142 https://www.grid.ac/institutes/grid.11899.38
143 schema:sameAs https://app.dimensions.ai/details/grant/grant.7443422
144 schema:sdDatePublished 2019-03-07T11:28
145 schema:sdLicense https://scigraph.springernature.com/explorer/license/
146 schema:sdPublisher N8027ccbd0f0c457280baa9f2b5607183
147 schema:startDate 2017-10-01T00:00:00Z
148 schema:url http://www.bv.fapesp.br/pt/auxilios/98008/inct-2014-nanotecnologia-farmaceutica-uma-abordagem-transdisciplinar-proc-n-201450928-2-vit/
149 sgo:license sg:explorer/license/
150 sgo:sdDataset grants
151 rdf:type schema:MonetaryGrant
152 N3bb025afe6134940bd303b9887afdb88 schema:member sg:person.01052663343.31
153 schema:roleName PI
154 rdf:type schema:Role
155 N61551ed5e5b740a3987a3eb39738d81e schema:name dimensions_id
156 schema:value 7443422
157 rdf:type schema:PropertyValue
158 N8027ccbd0f0c457280baa9f2b5607183 schema:name Springer Nature - SN SciGraph project
159 rdf:type schema:Organization
160 Nd332aad5d1a2434cb9311ed9e32df5ab schema:name fapesp_id
161 schema:value 17/17076-0
162 rdf:type schema:PropertyValue
163 anzsrc-for:2203 schema:inDefinedTermSet anzsrc-for:
164 rdf:type schema:DefinedTerm
165 sg:person.01052663343.31 schema:affiliation https://www.grid.ac/institutes/grid.11899.38
166 schema:familyName Bentley
167 schema:givenName Maria
168 rdf:type schema:Person
169 https://www.grid.ac/institutes/grid.11899.38 schema:name Universidade de São Paulo
170 rdf:type schema:Organization
171 https://www.grid.ac/institutes/grid.452907.d schema:Organization
 




Preview window. Press ESC to close (or click here)


...